Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
AssigneeAbbott Laboratories
InventorsRACHAEL BUCK, GERALYN O. DUSKA-MCEWEN, JOSEPH P. SCHALLER
Life of this patent
Estimating the term…
Abstract
Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
Claims20
A synthetic pediatric formula comprising:
- hydrolyzed protein;
- from about 0.01 mg/mL to about 10 mg/mL of at least one of 6′-sialyllactose, 3′-sialyllactose 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, and lacto-N-fucopentaose;
- from about 0.080 mg/mL to about 0.250 mg/mL of arachidonic acid;
- from about 0.001 μg/mL to about 5 μg/mL of at least one of lutein, lycopene, and beta-carotene;
- from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;
- wherein the synthetic pediatric formula is shelf stable for at least 3 months.
The synthetic pediatric formula of claim I, wherein at least one monomeric monophosphate nucleotide is a free acid and at least one other monomeric monophosphate nucleotide is a salt.
A synthetic pediatric formula comprising:
- hydrolyzed protein;
- from about 0.01 mg/mL to about 10 mg/mL of at least one of 2′-fucosyllactose, 3-fucosyllactose, 6′-sialyllactose, 3′-sialylactose, and lacto-N-tetraose;
- from about 0.080 mg/mL to about 0.250 mg/mL of arachidonic acid;
- from about 0.001 μg/mL to about 5 μg/mL of at least one of lutein, lycopene, and beta-carotene;
- from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;
- and
- wherein the synthetic pediatric formula is shelf stable from about 3 months to about 24 months.
A method of reducing inflammation in an infant, toddler, or child in need thereof, the method comprising administering to the infant, toddler, or child a synthetic pediatric formula comprising:
- hydrolyzed protein;
- from about 0.01 mg/mL to about 10 mg/mL of at least one of 6′-sialyllactose, 3′-sialyllactose 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, and lacto-N-neotetraose:
- from about 0.080 mg/mL to about 0.250 mg/mL of arachidonic acid;
- from about 0.001 μg/mL to about 5 μg/mL of at least one of lutein, lycopene, and beta-carotene;
- from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;
- wherein the synthetic pediatric formula is shelf stable for at least 3 months.
Dependencies are inferred from the claim text.